California State Teachers Retirement System (CalSTRS)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-36,068
Closed -$138K 3109
2020
Q1
$138K Buy
36,068
+407
+1% +$1.89K ﹤0.01% 2710
2019
Q4
$215K Hold
35,661
﹤0.01% 2769
2019
Q3
$270K Buy
35,661
+3,650
+11% +$41.1K ﹤0.01% 2660
2019
Q2
$434K Buy
+32,011
New +$370K ﹤0.01% 2435
2018
Q2
Sell
-18,035
Closed -$157K 3075
2018
Q1
$157K Sell
18,035
-353
-2% -$3.81K ﹤0.01% 2855
2017
Q4
$230K Sell
18,388
-912
-5% -$10.5K ﹤0.01% 2786
2017
Q3
$161K Sell
19,300
-900
-4% -$9.52K ﹤0.01% 2919
2017
Q2
$343K Buy
+20,200
New +$402K ﹤0.01% 2688
2016
Q2
Sell
-7,528
Closed -$71K 3054
2016
Q1
$71K Buy
7,528
+1,128
+18% +$9.1K ﹤0.01% 2936
2015
Q4
$64K Buy
6,400
+100
+2% +$1.32K ﹤0.01% 2990
2015
Q3
$90K Buy
+6,300
New +$155K ﹤0.01% 2990

Other funds holding ZYNE

California State Teachers Retirement System (CalSTRS)'s ZYNE Position: Q2 2020 in Review

California State Teachers Retirement System (CalSTRS) sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 36,068 shares — an estimated $138K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ZYNE in Q3 2015 and held it in 11 quarters. The position peaked at $434K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 36,068 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $138K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2015 and held it in 11 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Zynerba Pharmaceuticals, Inc position peaked at $434K in Q2 2019.
  • 74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2020, filed 17 Aug 2020.